Skip to main content
. 2021 Mar 20;268(9):3456–3466. doi: 10.1007/s00415-021-10516-7

Table 1.

Demographic and clinical characteristics of SCA3 patients and healthy controls. Data are presented as mean ± SD or frequency (percentage)

SCA3 patients Healthy controls
Age (y) 51.9 ± 10.0 52.9 ± 6.6
Male, n (%) 12 (60) 10 (55.6)
Educational level (y) 18.5 ± 4.0 19.7 ± 2.9
Disease duration (y) 8.0 ± 5.4
SARA score 11.9 ± 3.9
Number of repeats at expanded allele 67.6 ± 3.4